• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调节性T细胞与动脉粥样硬化

Regulatory T cells and Atherosclerosis.

作者信息

Pastrana Jahaira Lopez, Sha Xiaojin, Virtue Anthony, Mai Jietang, Cueto Ramon, Lee In Ae, Wang Hong, Yang Xiao-Feng

机构信息

Cardiovascular Research Center, Department of Pharmacology and Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA 19140.

出版信息

J Clin Exp Cardiolog. 2012 Oct 8;2012(Suppl 12):2. doi: 10.4172/2155-9880.S12-002.

DOI:10.4172/2155-9880.S12-002
PMID:23997979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3757946/
Abstract

Atherosclerosis is a chronic autoimmune inflammatory disease. The involvement of both innate and adaptive immune responses in the pathogenesis of the disease has been well recognized. Tregs are an essential part of the immune system and have indispensable functions in maintaining immune system homeostasis, mediating peripheral tolerance, preventing autoimmune diseases, and suppressing inflammatory and proatherogenic immune response. Tregs carry out their immunosuppressive functions via several mechansims. One of the well-documented suppressive mechanisms of Tregs is the secretion of anti-inflammatory cytokines including IL-10, TGF-β, and IL-35. Studies have found that IL-10 and TGF-β have atheroprotective properties. In addition, Tregs can suppress the activity of proatherogenic effector T cells, suggesting an atheroprotective role. In fact, fewer Tregs are found in atherogenic -/- mice comparing to wild-type mice, suggesting an uncontrolled balance between weakened Tregs and effector T cells in atherogenesis. Some clinical studies of autoimmune diseases also suggest that decreased Tregs numbers are associated with increased disease activity. The importance of Tregs in many autoimmune diseases and experimental atherosclerosis has been established in and studies. However, the roles of Tregs in atherosclerosis in the clinical setting remains to be further characterized.

摘要

动脉粥样硬化是一种慢性自身免疫性炎症性疾病。固有免疫反应和适应性免疫反应在该疾病发病机制中的参与已得到充分认识。调节性T细胞(Tregs)是免疫系统的重要组成部分,在维持免疫系统稳态、介导外周耐受、预防自身免疫性疾病以及抑制炎症和促动脉粥样硬化免疫反应方面具有不可或缺的作用。Tregs通过多种机制发挥其免疫抑制功能。Tregs有充分文献记载的抑制机制之一是分泌抗炎细胞因子,包括白细胞介素-10(IL-10)、转化生长因子-β(TGF-β)和白细胞介素-35(IL-35)。研究发现,IL-10和TGF-β具有抗动脉粥样硬化特性。此外,Tregs可抑制促动脉粥样硬化效应T细胞的活性,提示其具有抗动脉粥样硬化作用。事实上,与野生型小鼠相比,在动脉粥样硬化模型的基因敲除小鼠中发现的Tregs较少,这表明在动脉粥样硬化过程中,Tregs减弱与效应T细胞之间的平衡失控。一些自身免疫性疾病的临床研究也表明,Tregs数量减少与疾病活动增加有关。Tregs在许多自身免疫性疾病和实验性动脉粥样硬化中的重要性已在相关研究中得到证实。然而,Tregs在临床环境中动脉粥样硬化中的作用仍有待进一步明确。

相似文献

1
Regulatory T cells and Atherosclerosis.调节性T细胞与动脉粥样硬化
J Clin Exp Cardiolog. 2012 Oct 8;2012(Suppl 12):2. doi: 10.4172/2155-9880.S12-002.
2
Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis.用热休克蛋白60进行鼻内免疫可诱导CD4(+) CD25(+) GARP(+)和1型调节性T细胞,并抑制早期动脉粥样硬化。
Clin Exp Immunol. 2016 Mar;183(3):452-68. doi: 10.1111/cei.12726. Epub 2015 Nov 24.
3
Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response.动脉粥样硬化中的调节性 T 细胞及诱导内源性抗动脉粥样硬化免疫应答的策略。
Immunol Lett. 2013 Mar;151(1-2):10-22. doi: 10.1016/j.imlet.2013.01.014. Epub 2013 Feb 11.
4
CD4+LAP + and CD4 +CD25 +Foxp3 + regulatory T cells induced by nasal oxidized low-density lipoprotein suppress effector T cells response and attenuate atherosclerosis in ApoE-/- mice.鼻内氧化型低密度脂蛋白诱导的 CD4+LAP+和 CD4+CD25+Foxp3+调节性 T 细胞抑制效应 T 细胞反应,减轻 ApoE-/-小鼠的动脉粥样硬化。
J Clin Immunol. 2012 Oct;32(5):1104-17. doi: 10.1007/s10875-012-9699-7. Epub 2012 May 3.
5
Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential.动脉粥样硬化中的调节性T细胞:关键的免疫调节功能及治疗潜力
Cell Mol Life Sci. 2016 Mar;73(5):901-22. doi: 10.1007/s00018-015-2080-2. Epub 2015 Oct 30.
6
FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.FOXP3+ 调节性 T 细胞:从排斥抑制到诱导肾移植耐受。
Transpl Immunol. 2012 Jan;26(1):1-10. doi: 10.1016/j.trim.2011.08.009. Epub 2011 Sep 13.
7
Hematopoietic PI3Kδ deficiency aggravates murine atherosclerosis through impairment of Tregs.造血细胞 PI3Kδ 缺陷通过损害调节性 T 细胞加重小鼠动脉粥样硬化。
JCI Insight. 2024 Nov 22;9(22):e155626. doi: 10.1172/jci.insight.155626.
8
Treating atherosclerosis with regulatory T cells.用调节性 T 细胞治疗动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):280-7. doi: 10.1161/ATVBAHA.114.303568. Epub 2014 Nov 20.
9
Interleukin-4 Supports the Suppressive Immune Responses Elicited by Regulatory T Cells.白细胞介素-4支持调节性T细胞引发的免疫抑制反应。
Front Immunol. 2017 Nov 14;8:1508. doi: 10.3389/fimmu.2017.01508. eCollection 2017.
10
CD27 co-stimulation increases the abundance of regulatory T cells and reduces atherosclerosis in hyperlipidaemic mice.CD27 共刺激可增加调节性 T 细胞的丰度,减少高脂血症小鼠的动脉粥样硬化。
Eur Heart J. 2017 Dec 21;38(48):3590-3599. doi: 10.1093/eurheartj/ehx517.

引用本文的文献

1
High-density lipoproteins. Part 2. Impact of disease states on functionality.高密度脂蛋白。第2部分。疾病状态对功能的影响。
Am J Prev Cardiol. 2025 Aug 7;23:101073. doi: 10.1016/j.ajpc.2025.101073. eCollection 2025 Sep.
2
Vascular endothelial cell injury: causes, molecular mechanisms, and treatments.血管内皮细胞损伤:原因、分子机制及治疗方法。
MedComm (2020). 2025 Jan 16;6(2):e70057. doi: 10.1002/mco2.70057. eCollection 2025 Feb.
3
Immune Checkpoints Are New Therapeutic Targets in Regulating Cardio-, and Cerebro-Vascular Diseases and CD4Foxp3 Regulatory T Cell Immunosuppression.免疫检查点是调节心脑血管疾病和CD4Foxp3调节性T细胞免疫抑制的新治疗靶点。
Int J Drug Discov Pharm. 2024 Dec;3(4). doi: 10.53941/ijddp.2024.100022. Epub 2024 Nov 26.
4
Treg cells promote decidual vascular remodeling and modulate uterine NK cells in pregnant mice.调节性T细胞促进妊娠小鼠蜕膜血管重塑并调节子宫自然杀伤细胞。
JCI Insight. 2024 Dec 10;10(2):e169836. doi: 10.1172/jci.insight.169836.
5
Thymus in Cardiometabolic Impairments and Atherosclerosis: Not a Silent Player?胸腺在心脏代谢损伤和动脉粥样硬化中的作用:它并非沉默的参与者?
Biomedicines. 2024 Jun 25;12(7):1408. doi: 10.3390/biomedicines12071408.
6
Cholesterol and Cytokines: Molecular Links to Atherosclerosis and Carcinogenesis.胆固醇与细胞因子:动脉粥样硬化与癌变的分子联系。
Cell Biochem Biophys. 2024 Sep;82(3):1837-1844. doi: 10.1007/s12013-024-01383-w. Epub 2024 Jun 28.
7
The role of γδT lymphocytes in atherosclerosis.γδT 淋巴细胞在动脉粥样硬化中的作用。
Front Immunol. 2024 May 7;15:1369202. doi: 10.3389/fimmu.2024.1369202. eCollection 2024.
8
T cell specific deletion of Casitas B lineage lymphoma-b reduces atherosclerosis, but increases plaque T cell infiltration and systemic T cell activation.T 细胞特异性敲除 Casitas B 细胞淋巴瘤-b 可减少动脉粥样硬化,但增加斑块 T 细胞浸润和全身 T 细胞活化。
Front Immunol. 2024 Mar 4;15:1297893. doi: 10.3389/fimmu.2024.1297893. eCollection 2024.
9
Cells in Atherosclerosis: Focus on Cellular Senescence from Basic Science to Clinical Practice.动脉粥样硬化中的细胞:从基础科学到临床实践聚焦于细胞衰老。
Int J Mol Sci. 2023 Dec 5;24(24):17129. doi: 10.3390/ijms242417129.
10
Mass cytometry analysis reveals altered immune profiles in patients with coronary artery disease.质谱流式细胞术分析揭示了冠心病患者免疫图谱的改变。
Clin Transl Immunology. 2023 Nov 2;12(11):e1462. doi: 10.1002/cti2.1462. eCollection 2023.

本文引用的文献

1
Immune response to lipoproteins in atherosclerosis.动脉粥样硬化中对脂蛋白的免疫反应。
Cholesterol. 2012;2012:571846. doi: 10.1155/2012/571846. Epub 2012 Aug 23.
2
Deaths: final data for 2008.死亡情况:2008年最终数据。
Natl Vital Stat Rep. 2011 Dec 7;59(10):1-126.
3
Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke.循环中 CD4+FoxP3+T 细胞水平低与心肌梗死的发展风险增加相关,但与中风无关。
Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):2000-4. doi: 10.1161/ATVBAHA.112.251579. Epub 2012 May 24.
4
Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques.易损斑块患者的调节性 T 细胞和 IL-10 水平降低。
Atherosclerosis. 2012 Jun;222(2):519-23. doi: 10.1016/j.atherosclerosis.2012.03.016. Epub 2012 Apr 6.
5
CD4+LAP + and CD4 +CD25 +Foxp3 + regulatory T cells induced by nasal oxidized low-density lipoprotein suppress effector T cells response and attenuate atherosclerosis in ApoE-/- mice.鼻内氧化型低密度脂蛋白诱导的 CD4+LAP+和 CD4+CD25+Foxp3+调节性 T 细胞抑制效应 T 细胞反应,减轻 ApoE-/-小鼠的动脉粥样硬化。
J Clin Immunol. 2012 Oct;32(5):1104-17. doi: 10.1007/s10875-012-9699-7. Epub 2012 May 3.
6
Regulatory T cells in atherogenesis.调节性 T 细胞在动脉粥样形成中的作用。
J Atheroscler Thromb. 2012;19(6):503-15. doi: 10.5551/jat.10934. Epub 2012 Apr 10.
7
IL-35 is a novel responsive anti-inflammatory cytokine--a new system of categorizing anti-inflammatory cytokines.白细胞介素 35 是一种新型反应性抗炎细胞因子——一种新的抗炎细胞因子分类系统。
PLoS One. 2012;7(3):e33628. doi: 10.1371/journal.pone.0033628. Epub 2012 Mar 16.
8
Statins induce the accumulation of regulatory T cells in atherosclerotic plaque.他汀类药物可诱导粥样斑块中调节性 T 细胞的积累。
Mol Med. 2012 May 9;18(1):598-605. doi: 10.2119/molmed.2011.00471.
9
Regulatory T-cell response to apolipoprotein B100-derived peptides reduces the development and progression of atherosclerosis in mice.调节性 T 细胞对载脂蛋白 B100 衍生肽的反应可减少小鼠动脉粥样硬化的发生和发展。
Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):605-12. doi: 10.1161/ATVBAHA.111.242800. Epub 2012 Jan 5.
10
Attenuated atherosclerotic lesions in apoE-Fcγ-chain-deficient hyperlipidemic mouse model is associated with inhibition of Th17 cells and promotion of regulatory T cells.载脂蛋白 E-Fcγ 链缺陷型高脂血症小鼠模型中动脉粥样硬化病变的减弱与 Th17 细胞的抑制和调节性 T 细胞的促进有关。
J Immunol. 2011 Dec 1;187(11):6082-93. doi: 10.4049/jimmunol.1004133. Epub 2011 Oct 31.